Skip to content

Clinical trials

Rhabdomyosarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rhabdomyosarcoma Country / region: United States Clear all

175 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20022
20033
20044
20051
20067
20077
20086
20093
20107
20117
20126
20138
20144
20158
20169
201712
20187
20196
20209
202111
20227
20232
20246
20258
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed93
Recruiting27
Active, not recruiting25
Terminated17
Withdrawn5
Not yet recruiting4
Unknown status2
No longer available1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)38
St. Jude Children's Research Hospital16
Children's Oncology Group12
Baylor College of Medicine7
Memorial Sloan Kettering Cancer Center6
Emory University5
Eli Lilly and Company4
Seattle Children's Hospital4
Children's National Research Institute3
City of Hope Medical Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rhabdomyosarcoma175
Sarcoma101
Sarcoma, Ewing94
Osteosarcoma83
Neuroblastoma82
Wilms Tumor55
Rhabdoid Tumor39
Medulloblastoma36
Hepatoblastoma32
Neuroectodermal Tumors, Primitive, Peripheral32

Trials

Showing 26 to 50 of 175. Each trial links to its page on Pharma Observatory.

75 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.